Previous studies in colon carcinoma and multiple myeloma models showed that tumors with BCL9 KD exhibited altered expression and distribution of mesenchymal and epithelial markers, vimentin, β-catenin and E-cadherin, indicative of reduced EMT [11]. Here, CDH1 is linked to colon carcinoma.